BW12C perturbs normal and tumour tissue oxygenation and blood flow in man

This publication has 11 references indexed in Scilit:

• Phase I study of BW12C in combination with mitomycin C in patients with advanced gastrointestinal cancer
  International Journal of Radiation Oncology*Biology*Physics, 1992
• The influence of carbogen breathing on tumour tissue oxygenation in man evaluated by computerised p02 histography
  British Journal of Cancer, 1992
• BW12C-induced changes in haemoglobin-oxygen affinity in mice and its influence on the radiation response of a C3H mouse mammary carcinoma
  Radiotherapy and Oncology, 1992
• BW12C: effects on tumour hypoxia, tumour thermosensitivity and relative tumour and normal tissue perfusion in C3H mice
  British Journal of Cancer, 1991
• Measurement of tissue perfusion by dynamic computed tomography
  The British Journal of Radiology, 1991
• Colour perfusion imaging: a new application of computed tomography
  The Lancet, 1991
• Tumor tissue oxygenation as evaluated by computerized-po2-histography
  International Journal of Radiation Oncology*Biology*Physics, 1990
• Manipulation of oxygenation in a human tumour xenograft with BW12C or hydralazine : effects on responses to radiation and to the bioreductive cytotoxicity of misonidazole or RSU-1069
  Radiotherapy and Oncology, 1989
• The effects in volunteers of BW12C, a compound designed to left‐shift the blood‐oxygen saturation curve.
  British Journal of Clinical Pharmacology, 1985
• The hypoxic tumor cell: A target for selective cancer chemotherapy
  Biochemical Pharmacology, 1980